Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer NCT05415709 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Primary Periton...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Carboplatin
Cisplatin
Cytoreductive S...
Hyperthermic In...
Paclitaxel
Quality-of-Life...
Questionnaire A...
18 Years - Ohio State University Comprehensive Cancer Center View Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery NCT03943173 BRCA-Mutated Ov...
BRCA1 Gene Muta...
BRCA2 Gene Muta...
High Grade Fall...
High Grade Ovar...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Olaparib
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center View Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients NCT05047926 Advanced Ovaria...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Behavioral Coun...
Nutritional Sup...
Physical Activi...
Survey Administ...
Computed Tomogr...
Biospecimen Col...
Health Educatio...
Medical Device ...
18 Years - Mayo Clinic View ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer NCT05368506 Advanced Fallop...
Advanced Ovaria...
Advanced Primar...
Anatomic Stage ...
Metastatic Trip...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Wee1 Inhibitor ...
18 Years - OHSU Knight Cancer Institute View Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373 Advanced Breast...
Advanced Endome...
Advanced Fallop...
Advanced Hepato...
Advanced Malign...
Advanced Malign...
Advanced Malign...
Advanced Ovaria...
Advanced Primar...
Advanced Renal ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Malignant Abdom...
Malignant Solid...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic Hepa...
Metastatic Mali...
Metastatic Mali...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Metastatic Rena...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Fallo...
Stage III Hepat...
Stage III Ovari...
Stage III Prima...
Stage III Renal...
Stage III Uteri...
Stage IIIA Fall...
Stage IIIA Hepa...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Hepa...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Fallop...
Stage IV Hepato...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Hepat...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Hepat...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Atezolizumab
Cabozantinib S-...
Nab-paclitaxel
Tumor Treating ...
18 Years - M.D. Anderson Cancer Center View Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer NCT04673448 Anatomic Stage ...
Anatomic Stage ...
BRCA-Associated...
BRCA-Associated...
Metastatic BRCA...
Metastatic Brea...
Metastatic Fall...
Metastatic Mali...
Metastatic Ovar...
Metastatic Panc...
Metastatic Prim...
Prognostic Stag...
Prognostic Stag...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Br...
Unresectable Fa...
Unresectable Ma...
Unresectable Ov...
Unresectable Pa...
Unresectable Pr...
Dostarlimab
Niraparib
18 Years - University of Washington View ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer NCT05368506 Advanced Fallop...
Advanced Ovaria...
Advanced Primar...
Anatomic Stage ...
Metastatic Trip...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Wee1 Inhibitor ...
18 Years - OHSU Knight Cancer Institute View Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT03735589 Stage II Fallop...
Stage II Ovaria...
Stage II Primar...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Prima...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Prima...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Alpha-type-1 Po...
Autologous Natu...
18 Years - Roswell Park Cancer Institute View Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors NCT04616534 Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI) View Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers NCT03968406 Malignant Femal...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Recurrent Vagin...
Stage IV Cervic...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IV Vagina...
Stage IVA Cervi...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVA Vagin...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Stage IVB Vagin...
Quality-of-Life...
Radiation Thera...
Talazoparib
18 Years - M.D. Anderson Cancer Center View Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer NCT05276973 Fallopian Tube ...
Fallopian Tube ...
Ovarian Endomet...
Ovarian High Gr...
Primary Periton...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Unresectable Fa...
Unresectable Fa...
Unresectable Ov...
Unresectable Ov...
Unresectable Pr...
Unresectable Pr...
Biopsy
Carboplatin
Ipatasertib
Paclitaxel
18 Years - National Cancer Institute (NCI) View Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors NCT04616534 Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI) View Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors NCT04616534 Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI) View Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis NCT03508570 Malignant Perit...
Malignant Retro...
Metastatic Cerv...
Metastatic Endo...
Metastatic Fall...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Peritoneal Carc...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Malig...
Recurrent Ovari...
Recurrent Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Ipilimumab
Laboratory Biom...
Nivolumab
Pharmacokinetic...
18 Years - M.D. Anderson Cancer Center View PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer NCT05465941 Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Biopsy
Pegylated SN-38...
Computed Tomogr...
Biospecimen Col...
18 Years - Mayo Clinic View Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer NCT03907527 Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Fall...
Refractory Ovar...
Refractory Prim...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
PRGN-3005 Ultra...
PRGN-3005 Ultra...
18 Years - Precigen, Inc View Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients NCT05047926 Advanced Ovaria...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Behavioral Coun...
Nutritional Sup...
Physical Activi...
Survey Administ...
Computed Tomogr...
Biospecimen Col...
Health Educatio...
Medical Device ...
18 Years - Mayo Clinic View Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis NCT03508570 Malignant Perit...
Malignant Retro...
Metastatic Cerv...
Metastatic Endo...
Metastatic Fall...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Peritoneal Carc...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Malig...
Recurrent Ovari...
Recurrent Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Ipilimumab
Laboratory Biom...
Nivolumab
Pharmacokinetic...
18 Years - M.D. Anderson Cancer Center View Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935 Advanced Ovaria...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Laparotomy
Minimally Invas...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center View Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT03735589 Stage II Fallop...
Stage II Ovaria...
Stage II Primar...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Prima...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Prima...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Alpha-type-1 Po...
Autologous Natu...
18 Years - Roswell Park Cancer Institute View Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer NCT04498520 Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Hormone Recepto...
Locally Advance...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic HER2...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Brea...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Abexinostat Tos...
Fulvestrant
Palbociclib
18 Years - University of California, San Francisco View Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery NCT03943173 BRCA-Mutated Ov...
BRCA1 Gene Muta...
BRCA2 Gene Muta...
High Grade Fall...
High Grade Ovar...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Olaparib
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center View Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT04095364 Low Grade Fallo...
Ovarian Low Gra...
Primary Periton...
Stage II Fallop...
Stage II Ovaria...
Stage II Primar...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Biopsy
Biospecimen Col...
Carboplatin
Imaging Techniq...
Letrozole
Paclitaxel
18 Years - NRG Oncology View Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer NCT04498520 Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Hormone Recepto...
Locally Advance...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic HER2...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Brea...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Abexinostat Tos...
Fulvestrant
Palbociclib
18 Years - University of California, San Francisco View